Note: Ingredients listed on restricted chemical lists
EC/CAS
244-492-7/21645-51-2
Name of the chemical
Aluminium hydroxide
Concentration
10-25
EC/CAS
236-675-5/13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
1-5
EC/CAS
220-239-6/2682-20-4
Name of the chemical
2-Methyl-2H-isothiazol-3-one
Concentration
<0,01
EC/CAS
55965-84-9
Name of the chemical
Mixture of 5-chloro-2-methyl-2H- isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)
Concentration
<0,001
General Information
Version
5.3
Revision date
2024-11-08
Product name
CFS-CT / CP 670 / CP 673
1.2.1 Relevant identified uses
Professional use Industrial/Professional use spec
Emergency telephone
+49 (0)6132-84463
Icons in SDS
Company Information
company name
Hilti (Schweiz) AG
e-mail address of the competent person responsible for the Safety Data Sheet
info@hilti.ch, product.compliance-fire.protection@hilti.com
GHS Information
Signal word
Warning Contains Mixture of 5-chloro-2-methylisothiazol-3(2H)-one and 2-methylisothiazol-3(2H)-one ; 2- methyl-2H-isothiazol-3-one (MIT) Hazard statements (CLP) H317 - May cause an allergic skin reaction. Precautionary statements (CLP) P280 - Wear eye protection, protective clothing, protective gloves. P302+P352 - IF ON SKIN Wash with plenty of soap and water. P333+P313 - If skin irritation or rash occurs Get medical advice/attention
Hazard Codes
Hazard statements (CLP)
H317
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling
Hazard pictograms
GHS07
Signal word
Warning Contains Mixture of 5-chloro-2-methylisothiazol-3(2H)-one and 2-methylisothiazol-3(2H)-one ; 2- methyl-2H-isothiazol-3-one (MIT) Hazard statements (CLP) H317 - May cause an allergic skin reaction. Precautionary statements (CLP) P280 - Wear eye protection, protective clothing, protective gloves. P302+P352 - IF ON SKIN Wash with plenty of soap and water. P333+P313 - If skin irritation or rash occurs Get medical advice/attention
Supplemental label elements
EUH211 - Warning! Hazardous respirable droplets may be formed when sprayed. Do not breathe spray or mist
2.3 Other hazards
Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component aluminium hydroxide (21645-51-2) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Mixture of 5-chloro-2-methylisothiazol-3(2H)-one and 2-methylisothiazol-3(2H)-one (55965-84-9) hexaboron dizinc undecaoxide, heptahydrate (138265-88-0) 2-methyl-2H-isothiazol-3-one (MIT) (2682-20-4) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Titanium dioxide (13463-67-7) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component aluminium hydroxide (21645-51-2) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Titanium dioxide (13463-67-7) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 hexaboron dizinc undecaoxide, heptahydrate (138265-88-0) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Component 2-methyl-2H-isothiazol-3-one (MIT) (2682-20-4) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Mixture of 5-chloro-2-methylisothiazol-3(2H)-one and 2-methylisothiazol-3(2H)-one (55965-84-9) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605
